37 related articles for article (PubMed ID: 18215344)
1. Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses.
Perrais D; Ropert N
J Neurosci; 1999 Jan; 19(2):578-88. PubMed ID: 9880578
[TBL] [Abstract][Full Text] [Related]
2. Effect of Lipopolysaccharide on the Duration of Zolpidem-Induced Loss of Righting Reflex in Mice.
Wada Y; Ushio S; Kitamura Y; Zamami Y; Sendo T
Acta Med Okayama; 2024 Jun; 78(3):227-235. PubMed ID: 38902210
[TBL] [Abstract][Full Text] [Related]
3. Corelease of Inhibitory Neurotransmitters in the Mouse Auditory Midbrain.
Moore LA; Trussell LO
J Neurosci; 2017 Sep; 37(39):9453-9464. PubMed ID: 28847813
[TBL] [Abstract][Full Text] [Related]
4. Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.
Daniele A; Panza F; Greco A; Logroscino G; Seripa D
Parkinsons Dis; 2016; 2016():2531812. PubMed ID: 27293955
[TBL] [Abstract][Full Text] [Related]
5. Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal.
Brown RE; McKenna JT
Front Neurol; 2015; 6():135. PubMed ID: 26124745
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of short- and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABA(A) receptors in vitro.
Vlainić J; Jembrek MJ; Vlainić T; Strac DŠ; Peričić D
Acta Pharmacol Sin; 2012 Dec; 33(12):1469-76. PubMed ID: 22922343
[TBL] [Abstract][Full Text] [Related]
7. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
8. Topographic and functional neuroanatomical study of GABAergic disinhibitory striatum-nigral inputs and inhibitory nigrocollicular pathways: neural hodology recruiting the substantia nigra, pars reticulata, for the modulation of the neural activity in the inferior colliculus involved with panic-like emotions.
Castellan-Baldan L; da Costa Kawasaki M; Ribeiro SJ; Calvo F; Corrêa VM; Coimbra NC
J Chem Neuroanat; 2006 Aug; 32(1):1-27. PubMed ID: 16820278
[TBL] [Abstract][Full Text] [Related]
9. Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata.
Zhang LL; Chen L; Xue Y; Yung WH
Acta Pharmacol Sin; 2008 Feb; 29(2):161-8. PubMed ID: 18215344
[TBL] [Abstract][Full Text] [Related]
10. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus.
Chen L; Xie JX; Fung KS; Yung WH
Neurosci Res; 2007 May; 58(1):77-85. PubMed ID: 17337310
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological and behavioral effects of zolpidem in rat globus pallidus.
Chen L; Savio Chan C; Yung WH
Exp Neurol; 2004 Apr; 186(2):212-20. PubMed ID: 15026257
[TBL] [Abstract][Full Text] [Related]
12. GABAA receptor-mediated IPSCs and alpha1 subunit expression are not reduced in the substantia nigra pars reticulata of gerbils with inherited epilepsy.
Kumar SS; Wen X; Yang Y; Buckmaster PS
J Neurophysiol; 2006 Apr; 95(4):2446-55. PubMed ID: 16407426
[TBL] [Abstract][Full Text] [Related]
13. Alterations in GABAA receptor occupancy occur during the postnatal development of rat Purkinje cell but not granule cell synapses.
Wall MJ
Neuropharmacology; 2005 Oct; 49(5):596-609. PubMed ID: 15961127
[TBL] [Abstract][Full Text] [Related]
14. CNS 7056: a novel ultra-short-acting Benzodiazepine.
Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
